Product NDC: | 0143-9859 |
Proprietary Name: | Ceftriaxone |
Non Proprietary Name: | ceftriaxone |
Active Ingredient(s): | 250 mg/1 & nbsp; ceftriaxone |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | POWDER |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0143-9859 |
Labeler Name: | West-ward Pharmaceutical Corp |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA065342 |
Marketing Category: | ANDA |
Start Marketing Date: | 20080110 |
Package NDC: | 0143-9859-25 |
Package Description: | 1 POWDER in 1 VIAL (0143-9859-25) |
NDC Code | 0143-9859-25 |
Proprietary Name | Ceftriaxone |
Package Description | 1 POWDER in 1 VIAL (0143-9859-25) |
Product NDC | 0143-9859 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | ceftriaxone |
Dosage Form Name | POWDER |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 20080110 |
Marketing Category Name | ANDA |
Labeler Name | West-ward Pharmaceutical Corp |
Substance Name | CEFTRIAXONE SODIUM |
Strength Number | 250 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient] |